Contact this trialFirst, we need to learn more about you.
Anti-metabolites
Kamuvudine-8 for Age-Related Macular Degeneration
Recruiting1 awardPhase 1
Lexington, Kentucky
This trial is testing the safety and effectiveness of a drug called K8 for treating geographic atrophy (GA) in patients with age-related macular degeneration (AMD). Up to 5 patients will
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.